Clinical Trial Update: Safety and Efficacy of RX-af01 Combined With PD-1 Antibody [Phase 1, Phase 2]

View source ↗

Summary

Early-stage trial evaluating RX-af01 in combination with a PD-1 antibody shows safety and potential efficacy signals in solid tumors; overall results are not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)
• RX-af01

Snippet

Sponsor: Sun Yat-sen University | Conditions: Solid Tumor, Immune Checkpoint Inhibitor | Phase 1, Phase 2 | Status: UNKNOWN